{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:federal-register-2023-18241:v1","objectPathId":"federal-register-2023-18241-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/federal-register-2023-18241/","json":"https://peptidescanner.com/evidence/v1/objects/federal-register-2023-18241-v1.json","markdown":"https://peptidescanner.com/evidence/v1/objects/federal-register-2023-18241-v1.md"},"story":{"slug":"federal-register-2023-18241","version":1,"domain":"Regulatory","dateInSource":"2023-08-24","sourceCheckedAt":"2026-08-21","publishedAt":"2026-08-21","peptideSlugs":["exenatide"],"peptides":[{"slug":"exenatide","url":"https://peptidescanner.com/peptides/exenatide/"}]},"claims":[{"id":"headline","text":"Federal Register notice 2023-18241","sourceIds":["federal-register-2023-18241-d6c92e8889c0"]},{"id":"summary","text":"The Federal Register published notice 2023-18241, attributed to FDA and its parent HHS department, on 2023-08-24. Its official title is “Endocrinologic and Metabolic Drugs Advisory Committee; Notice of Alternative Form of Hearing,” and PeptideScanner's exact reviewed identity mapping connects the document to Exenatide.","sourceIds":["federal-register-2023-18241-d6c92e8889c0"]},{"id":"paragraph-1","text":"The Federal Register published notice 2023-18241, attributed to FDA and its parent HHS department, on 2023-08-24. Its official title is “Endocrinologic and Metabolic Drugs Advisory Committee; Notice of Alternative Form of Hearing,” and PeptideScanner's exact reviewed identity mapping connects the document to Exenatide.","sourceIds":["federal-register-2023-18241-d6c92e8889c0"]},{"id":"paragraph-2","text":"This page reports bounded metadata from a Federal Register document attributed to FDA and its parent HHS department, and links to the official GovInfo PDF. It does not interpret legal effect, approval, safety, effectiveness, compounding status, or medical use.","sourceIds":["federal-register-2023-18241-d6c92e8889c0"]}],"sources":[{"id":"federal-register-2023-18241-d6c92e8889c0","name":"Federal Register via GovInfo","sourceClass":"A","title":"Federal Register notice 2023-18241 · published 2023-08-24 · Endocrinologic and Metabolic Drugs Advisory Committee; Notice of Alternative Form of Hearing","url":"https://www.govinfo.gov/content/pkg/FR-2023-08-24/pdf/2023-18241.pdf"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reports the cited regulator or label record. It does not extend that record into broader safety, effectiveness, or approval claims.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"df7777794347daa93a5a8c7784ceb2fae7b89fd491375afba238f78fc44d3a0d","tierARecordSha256":"d6c92e8889c00d10497aaf407263adcd8a8f97a8f9c9a8f3470de7f2a2efd2e3"},"integrity":{"algorithm":"sha256","contentSha256":"fa0d617fb9c1e9dbba13806a964fc7d2972e3946d66186cd6764639fae349d9a"}}